Patent ID: 11884719
Assignee: 23ANDME, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 2:
3. The antibody of claim 1, wherein:
the light chain amino acid sequence has at least 90% identity to SEQ ID NO: 169 and the heavy chain amino acid sequence has at least 90% identity to a sequence selected from the group consisting of SEQ ID NOs: 191, 192, 193, 203, 204, 205, 233, 234, and 235; or
the light chain amino acid sequence has at least 90% identity to SEQ ID NO: 242 and the heavy chain amino acid sequence has at least 90% identity to a sequence selected from SEQ ID NOs: 170, 171, and 172.